UnitedHealth Group (UNH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Shareholders are invited to vote at the virtual annual meeting on June 2, 2025, with a focus on the Say on Pay proposal regarding executive compensation.
ISS reversed its recommendation on the Say on Pay proposal after the appointment of incoming CEO Steve Hemsley, citing concerns over his stock option award.
The Board and Compensation Committee emphasize the alignment of the CEO's compensation with shareholder interests and long-term value creation.
Voting matters and shareholder proposals
Shareholders are asked to support the Board's recommendations, particularly the Say on Pay proposal.
Glass Lewis recommends voting in favor of the Say on Pay proposal, while ISS recommends against it due to the CEO's compensation structure.
Shareholders can change their vote at any time before the annual meeting.
Board of directors and corporate governance
The Board required the incoming CEO to commit to a minimum three-year term.
The Board opted for a simple, clear compensation arrangement to maximize alignment with shareholders.
Latest events from UnitedHealth Group
- Margin improvement and operational turnaround are on track, with accelerated capital deployment.UNH
Wells Fargo 21st Annual Healthcare Conference - Q2 2026 revenue reached $112B, EPS $6.38, and guidance was raised on strong earnings and reforms.UNH
Q2 2026 - Director elections, executive pay, and auditor ratified; independent chair proposal failed.UNH
AGM 2026 - Performance award goals and results for executives will be disclosed after 2026-2028.UNH
Proxy filing - AI-driven growth, transparency, and operational efficiency are central to future performance.UNH
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue up 2% to $111.7B, adjusted EPS $7.23, outlook raised above $18.25.UNH
Q1 2026 - 2026 targets >8.6% EPS growth, margin expansion, and operational discipline amid membership declines.UNH
Q4 2025 - Q2 2025 revenue up 13%, but margins fell on higher medical costs and funding pressures.UNH
Q2 2025 - AI-driven value-based care and consumer focus fuel growth despite funding pressures.UNH
Investor Day 2024 - Hemsley returns as CEO; 2025 outlook suspended, margin recovery and growth targeted for 2026.UNH
Investor Update